RA Capital Management, L.P. 13D and 13G filings for Forma Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-10-14 4:03 pm Sale |
2022-10-14 | 13D | Forma Therapeutics Holdings, Inc. FMTX |
RA Capital Management, L.P. | 0 0.000% |
-9,040,309 (Position Closed) |
Filing |
| 2022-09-02 4:30 pm Purchase |
2022-08-31 | 13D | Forma Therapeutics Holdings, Inc. FMTX |
RA Capital Management, L.P. | 9,040,309 18.880% |
11,125 (+0.12%) |
Filing |
| 2021-10-28 4:32 pm Purchase |
2009-02-28 | 13D | Forma Therapeutics Holdings, Inc. FMTX |
RA Capital Management, L.P. | 9,029,184 19.050% |
17,533 (+0.19%) |
Filing |
| 2020-06-25 5:02 pm Purchase |
2009-02-28 | 13D | Forma Therapeutics Holdings, Inc. FMTX |
RA Capital Management, L.P. | 9,011,651 23.400% |
9,011,651 (New Position) |
Filing |